We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
-27.99%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$231M
AUM Growth
-$51.3M
Cap. Flow
-$18.2M
Cap. Flow %
-7.91%
Top 10 Hldgs %
82.16%
Holding
69
New
8
Increased
13
Reduced
20
Closed
14

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 18.79%
2 Healthcare 10.77%
3 Consumer Staples 10.29%
4 Financials 9.9%
5 Materials 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARA
26
DELISTED
Paramount Global Class B
PARA
$947K 0.41%
22,565
BDX icon
27
Becton Dickinson
BDX
$48.9B
$946K 0.41%
4,221
-352
-8% -$86.9K
TFX icon
28
Teleflex
TFX
$5.89B
$734K 0.32%
671
ONC
29
BeOne Medicines Ltd
ONC
$40.6B
$683K 0.3%
5,550
-103
-2% -$16.1K
ALXN
30
DELISTED
Alexion Pharmaceuticals
ALXN
$582K 0.25%
6,486
-1,063
-14% -$104K
DHR icon
31
Danaher
DHR
$147B
$497K 0.22%
4,053
-192
-5% -$25.9K
AMGN icon
32
Amgen
AMGN
$226B
$493K 0.21%
2,432
+1,192
+96% +$260K
REGN icon
33
Regeneron Pharmaceuticals
REGN
$83.2B
$464K 0.2%
950
-75
-7% -$30.9K
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$13.3B
$450K 0.2%
5,326
-212
-4% -$18.3K
CNC icon
35
Centene
CNC
$32.9B
$441K 0.19%
7,422
+977
+15% +$59.3K
CI icon
36
Cigna
CI
$73.6B
$418K 0.18%
2,357
-977
-29% -$190K
ASND icon
37
Ascendis Pharma A/S
ASND
$16.8B
$414K 0.18%
3,675
+270
+8% +$35.1K
BMY icon
38
Bristol-Myers Squibb
BMY
$132B
$380K 0.16%
6,824
+264
+4% +$16.1K
A icon
39
Agilent Technologies
A
$42B
$360K 0.16%
5,021
-1,900
-27% -$153K
MRK icon
40
Merck
MRK
$323B
$341K 0.15%
4,641
+240
+5% +$18.9K
AZN icon
41
AstraZeneca
AZN
$251B
$334K 0.14%
3,741
-98
-3% -$9.23K
HUM icon
42
Humana
HUM
$46.3B
$332K 0.14%
1,056
-99
-9% -$33.4K
DXCM icon
43
DexCom
DXCM
$33.1B
$325K 0.14%
+4,824
New +$300K
WCG
44
DELISTED
Wellcare Health Plans, Inc.
WCG
$320K 0.14%
969
SRPT icon
45
Sarepta Therapeutics
SRPT
$1.81B
$319K 0.14%
2,475
ABBV icon
46
AbbVie
ABBV
$438B
$312K 0.14%
+4,097
New +$349K
ELV icon
47
Elevance Health
ELV
$86.2B
$304K 0.13%
1,338
-1,138
-46% -$310K
HCA icon
48
HCA Healthcare
HCA
$89.6B
$303K 0.13%
3,373
-55
-2% -$7.12K
LLY icon
49
Eli Lilly
LLY
$1.1T
$268K 0.12%
1,935
-2,150
-53% -$295K
NBIX icon
50
Neurocrine Biosciences
NBIX
$16.8B
$264K 0.11%
3,047
-87
-3% -$8.51K

Similar funds

JGP Global Gestao de Recursos's Q1 2020 Portfolio in Review

As of Q1 2020, JGP Global Gestao de Recursos held 69 positions worth $231M, down 18% from $282M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $18.2M in Q1 2020, closing 14 positions and reducing 20 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $35.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, JGP Global Gestao de Recursos opened a new position in Vale worth $15.9M.

  • JGP Global Gestao de Recursos's largest Q1 2020 buy was Vale: 1,924,003 shares worth $15.9M.
  • JGP Global Gestao de Recursos added most to Arco Platform Limited Class A Common Shares in Q1 2020, an estimated $7.61M increase.
  • JGP Global Gestao de Recursos's biggest Q1 2020 reduction was Mercado Libre, cutting an estimated $21M.
  • JGP Global Gestao de Recursos fully exited iShares MSCI Emerging Markets ETF in Q1 2020, selling an estimated $35.9M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 82% of its $231M portfolio in Q1 2020.
  • JGP Global Gestao de Recursos opened 8 new positions and closed 14 in Q1 2020.
  • JGP Global Gestao de Recursos's portfolio value fell 18% quarter-over-quarter to $231M.

Based on JGP Global Gestao de Recursos's 13F filing for Q1 2020, filed 7 May 2020.